Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 8/2017

01-08-2017 | How to Do It

Double stenting with silicone and metallic stents for malignant airway stenosis

Authors: Keitaro Matsumoto, Naoya Yamasaki, Tomoshi Tsuchiya, Takuro Miyazaki, Ryotaro Kamohara, Go Hatachi, Takeshi Nagayasu

Published in: Surgery Today | Issue 8/2017

Login to get access

Abstract

For severe malignant airway stenosis, there are several types of commercially available airway stents, and each has its own advantages and disadvantages. We herein describe the safety and efficacy of combination stenting with silicone and metallic stents for patients with extended malignant airway stenosis. Seven patients with malignant airway stenosis were treated via combination stenting with a silicone stent and a metallic stent for extended airway stenosis from the central to peripheral airways. Five patients were diagnosed with advanced esophageal cancer, two of whom had tracheoesophageal fistulas. One patient had adenoid cystic carcinoma, and another had mediastinal tumor. There were no specific complications related to the double stenting. Combination stenting with silicone and metallic stents proved to be a safe option for patients with severe, extended, and complicated malignant airway stenosis.
Literature
1.
Seijo LM, Ancochea J. In search of the ideal tracheobronchial stent: metal or silicone? Arch Bronconeumol. 2004;40:293–94.CrossRefPubMed
2.
Freitag L, Tekolf E, Stamatis G, Greschuchna D. Clinical evaluation of a new bifurcated dynamic airway stent: a 5-year experience with 135 patients. Thorac Cardiovasc Surg. 1997;45:6–12.CrossRefPubMed
3.
Bolliger CT, Breitenbuecher A, Brutsche M, Heitz M, Stanzel F. Use of studded Polyflex stents in patients with neoplastic obstructions of the central airways. Respiration. 2004;71:83–7.CrossRefPubMed
4.
Gildea TR, Downie G, Eapen G, Herth F, Jantz M, Freitag L. A prospective multicenter trial of a self-expanding hybrid stent in malignant airway obstruction. J Bronchol. 2008;15:221–4.CrossRef
5.
Su JM, Wu TC, Wu MF, Chang H, Chou MC. Management of malignant tracheobronchial stenoses with the use of airway stents. J Chin Med Assoc. 2004;67:458-0.64.
6.
Lund ME, Garland R, Ernst A. Airway stenting: Applications and practice management considerations. Chest. 2007;131:579–87.CrossRefPubMed
7.
Kim J, Shin JH, Kim JH, Song HY, Song SY, Park CK. Metallic stent placement for the management of tracheal carina strictures and fistulas: technical and clinical outcomes. Am J Roentgenol. 2014;202:880–5.CrossRef
8.
Hamai Y, Hihara J, Emi M, Aoki Y, Miyata Y, Okada M. Airway stenting for malignant respiratory complications in esophageal cancer. Anticancer Res. 2012;32:1785–90.PubMed
9.
Furukawa K, Ishida J, Yamaguchi G, Usuda J, Tsutsui H, Saito M, et al. The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer. Surg Today. 2010;40:315–20.CrossRefPubMed
10.
Tsukioka T, Takahama M, Nakajima R, Kimura M, Tei K, Yamamoto R. Sequential stenting for extensive malignant airway stenosis. Ann Thorac Cardiovasc Surg. 2015;21:114–8.CrossRefPubMed
11.
Dutau H, Toutblanc B, Lamb C, Seijo L. Use of the Dumon Y-stent in the management of malignant disease involving the carina: a retrospective review of 86 patients. Chest. 2004;126:951–8.CrossRefPubMed
12.
Chung FT, Chen HC, Chou CL, Yu CT, Kuo CH, Kuo HP, Lin SM. An outcome analysis of self-expandable metallic stents in central airway obstruction: a cohort study. J Cardiothorac Surg. 2011;6:46–53.CrossRefPubMedPubMedCentral
13.
Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol. 2002;20:3578–85.CrossRefPubMed
14.
Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer. 2001;92:2639–47.CrossRefPubMed
15.
Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, et al; Spanish Lung Cancer Group. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. J Clin Oncol. 2003;21:3207–13.CrossRefPubMed
16.
Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–8.CrossRefPubMed
17.
Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277–84.CrossRefPubMed
18.
Van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.CrossRefPubMed
19.
Langer C, Lilenbaum R. Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer. Semin Oncol. 2004;31:8–15.CrossRefPubMed
20.
Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Shibata T. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula. Int J Radiat Oncol Biol Phys. 2008;70:1418–22.CrossRefPubMed
21.
Miyazaki T, Yamasaki N, Tsuchiya T, Matsumoto K, Takagi K, Nagayasu T. Airway stent insertion simulated with a three-dimensional printed airway model. Ann Thorac Surg. 2015;99:e21–e3.CrossRefPubMed
22.
23.
Saji H, Furukawa K, Tsutsui H, Tsuboi M, Ichinose S, Usuda J, et al. Outcomes of airway stenting for advanced lung cancer with central airway obstruction. Interact Cardiovasc Thorac Surg. 2010;11:425–8.CrossRefPubMed
24.
Chan KP, Eng P, Hsu AA, Huat GM, Chow M. Rigid bronchoscopy and stenting for esophageal cancer causing airway obstruction. Chest. 2002;122:1069–72.CrossRefPubMed
25.
Alexander EP, Trachiotis GD, Lipman TO, Wadleigh RG. Evolving management and outcome of esophageal cancer with airway involvement. Ann Thorac Surg. 2001;71:1640–4.CrossRefPubMed
26.
Belleguic C, Lena H, Briens E, Desrues B, Bretagne JF, Delaval P, et al. Tracheobronchial stenting in patients with esophageal cancer involving the central airways. Endoscopy. 1999;31:232–6.CrossRef
27.
Vonk-Noordegraaf A, Postmus PE, Sutedja TG. Tracheobronchial stenting in the terminal care of cancer patients with central airways obstruction. Chest. 2001;120:1811–4.CrossRefPubMed
28.
Gotoh M, Miyata H, Hashimoto H, Wakabayashi G, Konno H, Miyakawa S, et al. National Clinical Database feedback implementation for quality improvement of cancer treatment in Japan: from good to great through transparency. Surg Today. 2016;46:38–47.CrossRefPubMed
29.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
30.
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, Tsubosa Y, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.CrossRefPubMed
Metadata
Title
Double stenting with silicone and metallic stents for malignant airway stenosis
Authors
Keitaro Matsumoto
Naoya Yamasaki
Tomoshi Tsuchiya
Takuro Miyazaki
Ryotaro Kamohara
Go Hatachi
Takeshi Nagayasu
Publication date
01-08-2017
Publisher
Springer Japan
Published in
Surgery Today / Issue 8/2017
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-016-1466-6

Other articles of this Issue 8/2017

Surgery Today 8/2017 Go to the issue

Original Article

The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma

Original Article

The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity

Original Article

Histopathologic risk stratification of stage IIB colorectal cancer

Original Article

Timing and outcome of stoma closure in very low birth weight infants with surgical intestinal disorders

Original Article

The donor advocacy team: a risk management program for living organ, tissue, and cell transplant donors

Review Article

Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review